HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study

Marcel Yotebieng, Christian Mpody, Noro Lr Ravelomanana, Martine Tabala, Fathy Malongo, Bienvenu Kawende, Paul Ntangu, Frieda Behets, Emile Okitolonda, CQI-PMTCT study team, Marcel Yotebieng, Christian Mpody, Noro Lr Ravelomanana, Martine Tabala, Fathy Malongo, Bienvenu Kawende, Paul Ntangu, Frieda Behets, Emile Okitolonda, CQI-PMTCT study team

Abstract

Introduction: Published data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.

Methods: This cross-sectional study was conducted as part of a baseline assessment for the CQI-PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long-term ART outcomes among pregnant and breastfeeding women (NCT03048669). From November 2016 to June 2018, in each of the 35 Kinshasa provincial health zones (HZ), study teams visited the three busiest maternal and child health clinics, enrolled all HIV-positive pregnant or breastfeeding women (≤1 year post-delivery) receiving ART, and performed viral load testing. Log binomial models with generalized estimating equations to account for clustering at the HZ level, were used to estimate prevalence ratios comparing participants with undetected (<40 copies/mL) or suppressed (<1000 copies/mL) viral load across levels of individual and site characteristics.

Results: Of the 1752 eligible women, 1623 had viral load results available, including 38% who had been on ART for <6 months and 74% were on tenofovir-lamivudine-efavirenz. Viral load was undetectable in 53% of women and suppressed in 62%. Among women who were on ART for ≥12 months, only 60% and 67% respectively, had undetectable or suppressed viral load. Viral load was undetectable in 53%, 48% and 58% of women testing during pregnancy, at delivery, and in postpartum respectively. In multivariable log binomial models, duration of ART >12 months, older age, being married, disclosure of HIV status, receiving care in an urban health zone or one supported by PEPFAR were all positively associated with viral suppression.

Conclusions: The observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high-burden and limited resources settings like DRC.

Keywords: HIV; option B+; pregnant women; quality of care; treat all; universal coverage; vertical transmission; viral load monitoring; viral suppression.

© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Figures

Figure 1
Figure 1
Map and characteristics of enrolment sites.
Figure 2
Figure 2
Participants recruitment flowchart. *Other reasons include hearing impairment of participant, intent of participant to transfer to a different clinic, false pregnancy.
Figure 3
Figure 3
(a) Proportion of the 1623 women with viral load

Figure 4

Proportion of participants with viral…

Figure 4

Proportion of participants with viral load

Figure 4
Proportion of participants with viral load
Similar articles
Cited by
References
    1. UNAIDS . On the fast‐track to an AIDS free generation. 2016.
    1. UNAIDS . Start Free, Stay Free, AIDS Free: a super fast‐track framework for ending aids in children, adolescents, and young women by 2020. 2016.
    1. UNAIDS . Start free, stay free, AIDS free: 2017 progress report. 2017.
    1. Abuogi LL, Humphrey JM, Mpody C, Yotebieng M, Murnane PM, Clouse K, et al. Achieving UNAIDS 90‐90‐90 targets for pregnant and postpartum women in sub‐Saharan Africa: progress, gaps and research needs. J Virus Erad. 2018;4 Supplement 2:33–9. - PMC - PubMed
    1. Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta‐analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38. - PMC - PubMed
Show all 34 references
Publication types
MeSH terms
Related information
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 4
Figure 4
Proportion of participants with viral load

References

    1. UNAIDS . On the fast‐track to an AIDS free generation. 2016.
    1. UNAIDS . Start Free, Stay Free, AIDS Free: a super fast‐track framework for ending aids in children, adolescents, and young women by 2020. 2016.
    1. UNAIDS . Start free, stay free, AIDS free: 2017 progress report. 2017.
    1. Abuogi LL, Humphrey JM, Mpody C, Yotebieng M, Murnane PM, Clouse K, et al. Achieving UNAIDS 90‐90‐90 targets for pregnant and postpartum women in sub‐Saharan Africa: progress, gaps and research needs. J Virus Erad. 2018;4 Supplement 2:33–9.
    1. Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta‐analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38.
    1. Myer L, Dunning L, Lesosky M, Hsiao NY, Phillips T, Petro G, et al. Frequency of viremic episodes in HIV‐infected women initiating antiretroviral therapy during pregnancy: a cohort study. Clin Infect Dis. 2017;64(4):422–7.
    1. Yotebieng M, Thirumurthy H, Moracco KE, Edmonds A, Tabala M, Kawende B, et al. Conditional cash transfers to increase retention in PMTCT care, antiretroviral adherence, and postpartum virological suppression: a randomized controlled trial. J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S124–9.
    1. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low‐income, middle‐income, and high‐income countries: a systematic review and meta‐analysis. AIDS. 2012;26(16):2039–52.
    1. Haas AD, Msukwa MT, Egger M, Tenthani L, Tweya H, Jahn A, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program. Clin Infect Dis. 2016;63(9):1227–35.
    1. Myer L, Phillips TK, McIntyre JA, Hsiao NY, Petro G, Zerbe A, et al. HIV viraemia and mother‐to‐child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa. HIV Med. 2017;18(2):80–8.
    1. Yotebieng M, Behets F, Kawende B, Ravelomanana NL, Tabala M, Okitolonda EW. Continuous quality improvement interventions to improve long‐term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: design of an open‐label, parallel, group randomized trial. BMC Health Serv Res. 2017;17(1):306.
    1. International, M.d.P.e.M . Démographique et de Santé, République Démocratique du Congo 2013‐1014: Rapport Préliminaire sur la Prévalence du VIH. Calverton, MD: Ministère du Plan et Macro International; 2014.
    1. World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013.
    1. Boillot F, Serrano L, Muwonga J, Kabuayi JP, Kambale A, Mutaka F, et al. Implementation and operational research: programmatic feasibility of dried blood spots for the virological follow‐up of patients on antiretroviral treatment in NORD KIVU, Democratic Republic of the Congo. J Acquir Immune Defic Syndr. 2016;71:e9–15.
    1. Yotebieng M, Thirumurthy H, Moracco KE, Kawende B, Chalachala JL, Wenzi LK, et al. Conditional cash transfers and uptake of and retention in prevention of mother‐to‐child HIV transmission care: a randomised controlled trial. Lancet HIV. 2016;3:e85–93.
    1. Yotebieng M, Labbok M, Soeters HM, Chalachala JL, Lapika B, Vitta BS, et al. Ten Steps to Successful Breastfeeding programme to promote early initiation and exclusive breastfeeding in DR Congo: a cluster‐randomised controlled trial. Lancet Glob Health. 2015;3:e546–55.
    1. Maldonado G, Greenland S. Simulation study of confounder‐selection strategies. Am J Epidemiol. 1993;138(11):923–36.
    1. Pannus P, Claus M, Gonzalez MM, Ford N, Fransen K.Sensitivity and specificity of dried blood spots for HIV‐1 viral load quantification: a laboratory assessment of 3 commercial assays. Medicine (Baltimore). 2016;95:e5475.
    1. Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Mthiko BC, Phulusa J, et al. Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women. PLoS One. 2018;13:e0195033.
    1. Hosseinipour M, Nelson JAE, Trapence C, Rutstein SE, Kasende F, , Kayoyo V, et al. Viral suppression and HIV drug resistance at 6 months among women in Malawi's option B+ program: results from the PURE Malawi study. J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S149–55.
    1. UNAIDS . Global AIDS update 2018: Miles to go – closing gaps, breaking barriers, righting injustices. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2018.
    1. Yotebieng M, Moracco KE, Thirumurthy H, Edmonds A, Tabala M, Kawende B, et al. Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic. J Acquir Immune Defic Syndr. 2017;74(2):150–7.
    1. Ross J, Edmonds A, Hoover DR, Shi Q, Anastos K, Lelo P, et al. Association between pregnancy at enrollment into HIV care and loss to care among women in the Democratic Republic of Congo, 2006‐2013. PLoS One. 2018;13:e0195231.
    1. Gichane MW, Moracco KE, Thirumurthy H, Okitolonda EW, Behets F, Yotebieng M Intimate partner violence and prevention of mother to child transmission of HIV: evidence from Kinshasa, Democratic Republic of Congo. PLoS One. 2018;13:e0203471.
    1. Tchouwa GF, Eymard‐Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, et al. Nationwide estimates of viral load suppression and acquired HIV drug resistance in cameroon. EClinicalMedicine. 2018;1:21–7.
    1. Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, et al. Research priorities to inform “Treat All” policy implementation for people living with HIV in sub‐Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019;22:e25218.
    1. Gill MM, Hoffman HJ, Bobrow EA, Mugwaneza P, Ndatimana D, Ndayisaba GF, et al. Detectable viral load in late pregnancy among women in the rwanda option B plus PMTCT program: enrollment results from the Kabeho Study. PLoS One. 2016;11:e0168671.
    1. Labhardt ND, Bader J, Ramoeletsi M, Kamele M, Lejone TI, Cheleboi M, et al. Clinical and socio‐demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART‐1. J Int AIDS Soc. 2014;17:115–6.
    1. Jasseron C, Mandelbrot L, Dollfus C Trocmé N, Tubiana R, Teglas JP, et al. Non‐disclosure of a pregnant woman's HIV status to her partner is associated with non‐optimal prevention of mother‐to‐child transmission. AIDS Behav. 2013;17(2):488–97.
    1. Brittain K, Mellins CA, Remien RH, Phillips T, Zerbe A, Abrams EJ, et al. Patterns and predictors of HIV‐status disclosure among pregnant women in South Africa: dimensions of disclosure and influence of social and economic circumstances. AIDS Behav. 2018;22(12):3933–44.
    1. Hunter‐Adams J, Zerbe A, Philips T, Rini Z, Myer L, Petro G, et al. The dimensionality of disclosure of HIV status amongst post‐partum women in Cape Town, South Africa. Afr J AIDS Res. 2017;16(2):101–7.
    1. Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools‐Kaloustian K, et al. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia‐Pacific, sub‐Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc. 2014;17:19045.
    1. Fritz CQ, Blevins M, Lindegren ML, Wools‐Kaloutsian K, Musick BS, Cornell M, et al. Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. J Int AIDS Soc. 2017;20(1):1–14.
    1. Gils T, Bossard C, Verdonck K, Owiti P, Casteels I, Mashako M, et al. Stockouts of HIV commodities in public health facilities in Kinshasa: barriers to end HIV. PLoS One. 2018;13:e0191294.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe